Newborn Metabolic, Endocrine and Hemoglobinopathy and the Newborn Hearing Loss Screening Programs Mandate
Customize your policy alerts
Sign up for all Blue Cross Blue Shield - Rhode Island policy alerts
Know when Blue Cross Blue Shield - Rhode Island releases new policies or updates existing guidance.
Monitor payer policy activity
Defines Rhode Island state-mandated coverage requirements for newborn metabolic, endocrine, hemoglobinopathy, and newborn hearing loss screening programs and who is responsible for testing and payment.
No material clinical or coverage changes in this revision.
Mandated Newborn Screening Coverage
Mandated Screening Coverage Criteria
Covered when statutory conditions apply and absent a valid religious objection:
Parents may object on religious grounds and testing shall not be performed in that case (R.I. Gen. Laws § 23-13-14).
Each confirmed newborn screening diagnosis and required case information must be reported to the Department within 90 days of confirmation.
Newborn hearing screening
Covered service statement with reference to detailed preventive policy
See 'Preventive Services for Commercial Members' for details and any specific criteria.
Rhode Island state-mandated newborn screening requirements do not apply to Medicare Advantage plans and may not apply to self-funded employer groups; verify group-specific benefits in the member's benefit booklet or subscriber agreement. Newborn hearing screening is required under R.I. Gen. Laws § 23-13-13, but testing shall not be performed if the parents object on religious grounds.
Benefits and eligibility are determined by the member's subscriber agreement or employer agreement; confirm member-specific coverage with the provider call center when necessary. If services are determined to be not medically necessary, or are non-covered benefits, the provider may not charge the member for those services unless the member was informed in advance and agreed in writing to accept financial responsibility.
Billing and Code Guidance
| 84999-32 | Unlisted code representing all tests performed by the Department of Health laboratory |
Provider Responsibilities and Billing Risk
Prior Authorization Not Applicable
Prior authorization is not required for Rhode Island–mandated newborn screening services.
- Applicable to mandated newborn screening tests and newborn hearing screening
Contract Exclusions May Trigger Denial
Benefits may vary between groups and contracts. Rhode Island state-mandated benefits do not apply to Medicare Advantage plans and may not apply to some self-funded groups. Contract exclusions or differing benefit designs may result in claim denials.
- Verify whether the member's group follows state mandates
- Refer to the member's Benefit Booklet, Evidence of Coverage, Subscriber Agreement, or employer agreement for coverage specifics
Verify Member Benefits and Billing Risk
For member-specific benefits, eligibility, or billing questions, contact the BCBSRI provider call center. If services are determined not medically necessary or are non-covered benefits, providers may not bill members unless the member was informed and agreed in writing in advance as allowed by the participation agreement.
- Call provider call center for verification of eligibility and benefits
- Obtain and document member written agreement before billing member for non-covered services when permitted by contract
Reporting Requirements for Laboratories and Confirmed Cases
All newborn screening test reports performed by laboratories must be submitted to the attending physician and the Rhode Island Department of Health and must include actual values and reference ranges. Confirmed newborn screening diagnoses, diagnostic test type, treatment type, and any additional information required by the Director must be reported to the Department within 90 days of confirmation.
- Laboratories must be approved by the Director to perform required newborn screening tests
- Department provides filter specimen slips and instructions to birthing facilities and attending clinicians
Background and Purpose
Newborn screening uses tests performed in the first days of life (typically a blood heel‑prick and a hearing screen) to identify metabolic, endocrine, hemoglobinopathy disorders and hearing loss that are not clinically apparent at birth. Early detection through the statewide screening program enables timely diagnostic evaluation and intervention to prevent death or disability.
Key Definitions and Legal References
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.